Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UBC Medical Indonesia Tbk. (LABS) vs Surya Fajar Capital Tbk. (SFAN) Price & Performance

UBC Medical Indonesia Tbk.Trade
Surya Fajar Capital Tbk.Trade

Price performance (Past 24H)

Key statistics

UBC Medical Indonesia Tbk. vs Surya Fajar Capital Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp168 (market cap 651.75B, 848.2K 24h volume), while Surya Fajar Capital Tbk. trades at Rp2,010 (market cap 2.73T, 42K 24h volume). The key difference: Surya Fajar Capital Tbk. is far larger — about 4.2× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (848.2K versus 42K). Which is the better fit depends on your goals.

LABSSFAN
Market Cap
651.75B2.73T
Volume
848.2K42K
Lot
8.48K420
Turnover
140.51M84.02M
Average Price
165.662,000.55
Value
140.51M84.02M
Indicative Equilibrium Price
1682,010
Indicative Equilibrium Volume
50300

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details
SFAN
View details

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS

About Surya Fajar Capital Tbk.

PT Surya Fajar Capital Tbk (the Company) was established based on Notarial Deed No. 12 dated April 5, 2016 of Humberg Lie, S.H., S.E., M.Kn., a public notary in North Jakarta.

Read more on SFAN